Autopsy report · NCT00022230

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

“PI left Institution”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Roger Williams Medical Center

Sponsor type

University, hospital or other

Conditions

Breast Cancer

Interventions

aldesleukin; filgrastim; sargramostim; therapeutic autologous lymphocytes; cyclophosphamide; doxorubicin hydrochloride

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
  “PI has left Institution” (96% match in meaning)
• Cilostazol After Lower Extremity Arterial Revascularization Trial
  “Original PI left institution” (94% match in meaning)
• rhBMP-2 Versus Vivigen in Lumbar Fusion Procedures
  “PI left the institution” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.